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Summary The aim of the study was to investigate the association between surface
electromyographic (EMG) activity of the diaphragm and intercostal muscles, and
clinical symptoms (wheeze, cough, increased respiratory rate and prolonged
expiration) during bronchial challenge testing and after administration of salbutamol
in asthmatic pre-school children.
A histamine challenge test was performed in 20 asthmatic pre-school children. The
histamine dose at the appearance of 1 or more clinical symptoms was defined as the
maximum histamine provocation dose (PDcs). The clinical symptoms were recorded
with a microphone over the trachea. The logarithm of the EMG-Activity-Ratio (log
EMGAR; mean peak activity ratio to baseline of respiratory muscles during tidal
breathing) was used as EMG parameter.
In both the diaphragmatic and the intercostal log EMGAR values a linear increase
was observed in the four histamine dose-steps prior to PDcs. At PDcs the mean log
EMGAR of the diaphragm (di) and intercostal muscles (int) was significantly increased
as compared to the baseline values. After administration of salbutamol the log
EMGARdi and log EMGARint returned to baseline values and the clinical symptoms
normalized in all children. At PDcs, no significant differences in the log EMGAR values
could be detected at the appearance of the distinctive clinical symptoms, which
suggests that wheezing is not the only indicator for the detection of airway
responsiveness in young children.
We found a linear association between histamine dose and the increase in surface
diaphragmatic and intercostal respiratory EMG activity during a bronchial challenge
test in pre-school asthmatic children, which returned to baseline values after
inhalation of salbutamol. These findings support the idea that EMG measurements of
the diaphragm and intercostal muscles may offer an opportunity to estimate airway
response in young children in an alternative way.
& 2003 Elsevier Ltd. All rights reserved.
Introduction
The accumulating evidence of an increased in-
cidence of asthma in early childhood and the
impact of early treatment on pulmonary function
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outcome both justify the development of reliable
methods to evaluate airflow limitation and bron-
chial responsiveness in the pre-school child.1,2
Several methods have been used to assess bronchial
responsiveness in this age group.3 However, most of
the methods are not used routinely because none of
them are easily applicable.
A method to assess bronchial responsiveness is
based on detecting audible clinical symptoms over
the chest or trachea.4–7 In earlier studies we found
in asthmatic school children that the appearance of
wheeze, cough, a prolonged expiration, and an
increased respiratory rate corresponded well with a
20% fall in FEV1 during a bronchial challenge test.
8,9
Wheeze by itself was found to be an insensitive
indicator for assessing bronchial responsiveness.
In the process of a study for a method to assess
airway response in an indirect way, allowing for a
minimum of co-operation from the child, we
developed a non-invasive technique for monitoring
respiratory muscle activity.10,11 In recent studies
we found that the respiratory EMG method corre-
lated with the maximum fall in FEV1 during a
histamine challenge in asthmatic school chil-
dren.10,11 Moreover, the respiratory EMG method
correlated well at different degrees of airflow
limitation and the signal appeared to be reprodu-
cible during tidal breathing with and without
airflow limitation in school children with asth-
ma.11,12 In pre-school children we showed that the
respiratory EMG method was reproducible during
tidal breathing without airflow limitation.12
The aim of the study was to investigate the
association between surface electromyographic
(EMG) activity of the diaphragm and intercostal
muscles, and clinical symptoms (wheeze, cough,
increased respiratory rate and prolonged expira-
tion) during bronchial challenge testing and after
administration of salbutamol in asthmatic pre-
school children.
Methods
Patients
A histamine challenge was performed in 20 pre-
school children (8 males, 12 females), between the
ages of 2 and 6. The children were diagnosed as
having asthma according to the International
Consensus Report on Diagnosis and Management of
Asthma13 and attended the outpatient clinic of the
Emma Children’s Hospital at the University Hospital
of Amsterdam. All suffered from recurrent periods
of coughing, wheezing and dyspnoea. Children with
lung diseases other than asthma were excluded
from participation in the study. All children were
free of complaints and symptoms of pulmonary
origin on the day of the measurements. All children
reacted well on b-adrenergic drugs and used these
drugs on demand. Thirteen children were treated
with inhaled corticosteroids. The children avoided
short and long acting bronchodilator therapy 8 and
24 h, respectively, before the measurements. In-
haled corticosteroid therapy was continued during
the study. The children were measured in an
upright sitting position with their hands resting on
their legs. The Medical Ethics Committee of the
University Hospital of Amsterdam approved the
study. Informed consent from the parents was
obtained prior to inclusion in the study.
Histamine challenge
For histamine inhalation we used a calibrated De
Villbiss 646 nebulizer (De Villbiss, Somerset, MA,
USA) with an output of 0.13ml/min. The aerosol
was delivered into a soft clear plastic facemask
(Vital Signs, Inc., Totowa, USA) to provide a good
seal on the patients, and inhaled through the
mouth. In order to avoid an effect of histamine on
nasal resistance all children wore a small nose clip,
so that the dead space was not increased. The
children inhaled an aerosol of 0.9% phosphate-
buffered saline solution (PBS) during 2min of tidal
breathing, as a control for the histamine-challenge
test. Subsequently, at 5-min intervals, doubled
histamine aerosol concentrations were adminis-
tered from 0.03mg/ml up to a maximum of 8mg/
ml during 2min of tidal breathing as well. In
between dose steps, clinical symptoms were
recorded over the trachea for 2min, starting
1min after administration of each dose of hista-
mine during quiet respiration. The provocation test
was terminated when 1 or more of the following
clinical symptoms were observed: (1) wheeze, (2)
persistent cough, (3) prolonged expiration, (4)
increased respiratory rate, or (5) when the max-
imum dose of histamine was reached. For definition
of the criteria see ‘Tracheal auscultation’. Bron-
chial responsiveness was defined as the histamine
provocation dose at which 1 or more of these
clinical symptoms was observed (PDcs). After
reaching the PDcs and/or the maximum dose of
histamine, 4 puffs of 100 mg salbutamol dose-
aerosol were administered with a Babyhaler. A 2-
min recording of the lung sounds was repeated
10min after inhalation of salbutamol to make sure
that the clinical symptoms normalized.
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Trachea auscultation
A microphone (Wip & Broos, Groningen, The
Netherlands) was placed in the suprasternal notch
and attached to the skin with two-sided adhesive
tape rings. The clinical symptoms were stored on
tape (DT-120 Rn, Sony), using a digital audio tape
recorder (DTC-59 ES, Sony). The clinical symptoms
were analysed directly by the investigator (E.M.)
and classified as wheeze, persistent cough, pro-
longed expiration, and increase in the respiratory
rate. Cough was scored when it appeared and was
persistent, defined as during 1min or more con-
tinuously coughing after inhalation of histamine.
Prolonged expiration was scored when the duration
of expiration exceeded the duration of inspiration.
An increase in the respiratory rate was defined as
an increase of 50% or more from the baseline
respiratory rate. As a control, a second analysis of
the clinical symptoms was performed from the
audio tape recordings. During this second analysis
the investigator was unaware of patient character-
istics and histamine concentrations.
Electromyographic recordings
A schematic presentation of the equipment used in
the study is shown in Fig. 1. Respiratory electro-
myographic (EMG) signals were recorded continu-
ously. Surface EMG of the diaphragm and
intercostal muscles was derived from pairs of single
electrodes (disposable Neotrode, ConMed Corpora-
tion, New York, USA). To obtain electrical activity
from the diaphragm, 2 electrodes were placed
bilaterally below the costal margin in the nipple
line. To obtain electrical activity from the inter-
costal muscles, 2 electrodes were placed bilater-
ally, 1 each in the second intercostal space left and
right. A common electrode was placed at the height
of the sternum.
The electrodes were connected to a portable
Porti-16 front-end (TMS International, Enschede,
The Netherlands) by means of shielded cables to
avoid interference pick-up. To prevent loss of
electrode signal to the cable capacity, a low
impedance version of this electrode signal was
fed back to the shield (guarding). The front-end
measured, conditioned and digitized the analogue
signals, and pre-processed the digital signals. The
Porti-16 front-end configuration comprises 8 bipo-
lar electro-physiological (EXG) channels and 8
differential physical (AUX) channels. The bipolar
EXG channels have high input impedances (42GO).
The common mode signal range is 6 V, the differ-
ential signal range is 300mV and the common mode
rejection ratio is 4100 dB at 50–60Hz. Analogue
high-pass or low-pass filters are absent so that the
analogue signals cannot be degraded before sam-
pling. Firstly, a surface EMG signal is not a periodic
signal but more or less random noise modulated by
muscle activity, so in principle an AA filter was not
needed. Secondly, the A–D converter as used was of
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Figure 1 Schematic presentation of the respiratory EMG recording and analysis equipment as used in the study. Note:
The electrodes for monitoring surface EMG of the diaphragm and intercostal muscles were placed bilaterally below the
costal margin in the nipple line, and 1 each in the second intercostal space left and right, respectively. The common
electrode was placed at the height of the sternum. The electrodes were connected to a portable Porti-16 front-end.
The data were recorded, processed and analysed by POLY 5.0 (see Methods).
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the sigma-delta type. The principle of this method
is in short that at a very high sample frequency
(570 kHz) a numeric representation of the signal
(sigma) is made by updating sigma with the
difference (delta) of the input signal and the
previous sigma. This updating is performed by
means of a high order digital low-pass (decimation)
filter. The data stream of the decimation filter is
sub-sampled with the output sample frequency.
The cut-off frequency of the digital filter is
automatically set to 0.34n the output sample
frequency, so acting as an inherent AA filter. To
prevent aliasing at the 570 kHz primary sample
frequency a simple first order low-pass analogue
filter at 5 kHz was sufficient. Although the max-
imum sample frequency of the front-end is 2 kHz,
the sensitivity for the detection of respiratory
muscle activity during tidal breathing was optimal
at a sample frequency of B400Hz. The ADC puts
out samples with a resolution of 22 bits, resulting in
a least significant bit of 71.5 nV for the differential
signal. The total amplifier and ADC noise is
o2 mVpp. The EXG signal was transformed into an
EMG signal by means of a digital first-order high-
pass filter (time constant¼ 0.01 s), as an electro-
physiological signal is characterized by the position
of the electrodes in relation to the electrically
active tissue and its signal properties.
Substantial heart activity (mainly QRS com-
plexes) interferes with the diaphragmatic and
intercostal EMG signals measured at the trunk. This
heart activity was removed from the respiratory
muscle activity as described by O’Brien et al.14 In
short, the QRS complexes were detected and
stretched to a standard pulse width of 100ms.
During this pulse a cut was made in the slightly
delayed (40ms) EMG signal in order to filter out the
QRS complexes completely (so-called ‘gated EMG’).
Next, the gated EMG was rectified and averaged
with a moving time window of T ¼ 200ms. Finally,
the missing signal in the gate was filled with the
running average resulting in a fairly good inter-
polation during the gate and an almost QRS-free
averaged EMG signal. More detailed technical
aspects of the measurements and measurement
devices were described in a recent paper.12
The EMGAR method is based on the relation of
the inspiratory neural drive needed to reach a
certain lung volume at a given test moment with
that at a reference moment, acting as baseline.
The peak in the averaged electrical activity of the
respiratory muscle represents the end of increasing
lung volume, the peak amplitude represents the
amount of neural drive necessary to reach end-
inspirational lung volume. To avoid contamination
of the peak values by tonic activity and instru-
mental noise, especially at low peak values, the
tonic activity was eliminated by the vectorial
subtraction of the bottom activity (containing the
vectorial sum of the tonic activity and the instru-
mental noise) from the peak values.
Data analysis and statistics
During the histamine challenge test, the respiratory
EMG signals were recorded continuously. To be able
to compare both methods, we selected the part of
the continuous EMG registration during tracheal
auscultation (2min in between histamine dose
steps, starting 1min after administration of each
dose of histamine) for data analyses. Cough periods
were isolated and eliminated from EMG recordings
used for calculating the EMGAR. For analysis of the
EMG signals we calculated the EMG-Activity-Ratio
(EMGAR),10 which can be represented as the ratio
of the mean peak-to-bottom averaged EMG value
during airway response and the mean peak-to-
bottom averaged EMG value at baseline. A loga-
rithmic conversion (log EMGAR) was used to make
the relative change in EMG activity symmetric
around the unity value. For example, a log EMGAR
of 1 means an increase in EMG activity with a factor
of 10, a log EMGAR of 1 means a decrease with a
factor of 10, compared to the baseline value. For
the calculation of the mean peak-to-bottom value a
minimum of 6 tidal breaths was used, as described
in detail in a recent paper.12 A two-tailed paired t-
test was used for statistical analysis. a pp0:05 was
considered to be statistically significant.
Results
The characteristics of the children and results
of the bronchial challenge tests are presented in
Table 1. All children had a positive challenge test
(PDcs). In all but 1 (child 11) challenges an increase
in diaphragmatic and intercostal EMG activity was
detected at the dose step at which 1 or more
clinical symptoms appeared (PDcs).
In Fig. 2, an example of the averaged diaphrag-
matic EMG recording during a bronchial challenge
test is shown (child 5). Both the diaphragmatic and
the intercostal EMGAR values increased in associa-
tion with the appearance of clinical symptoms
during the process of an increasing airway re-
sponse. However, during this process of airway
response alternating activity of the diaphragm
and intercostal muscles was observed in nine
individuals.
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Table 1 Characteristics of the children and results of bronchial challenge tests.
Child Age Histamine PDcs Log EMG-activity-ratio Clinical symptoms
No. (years) (mg/ml) Diaphragm Intercostal muscles
At PDcs After salb. At PDcs After salb. At PDcs Additional symptoms After salb.
1. 5.2 0.5 0.92 0.01 0.77 0.04 Wheeze Cough, prol. expir. None
2. 4.6 2.0 0.58 0.04 0.13 F Cough None
3. 3.5 8.0 0.47 0.23 0.72 0.01 Cough Prol. expir. None
4. 2.7 2.0 0.55 0.16 0.32 0.06 Wheeze Cough, prol. expir., respir. rate None
5. 4.3 0.5 0.34 0.08 0.56 0.09 Wheeze Cough, respir. rate None
6. 4.4 1.0 0.58 0.00 0.22 0.64 Wheeze Cough, prol. expir., respir. rate None
7. 5.5 2.0 0.53 0.10 0.41 0.14 Cough Prol. expir., respir. rate None
8. 6.3 8.0 0.26 0.13 1.19 0.16 Wheeze Cough, prol. expir., respir. rate None
9. 4.5 8.0 0.18 0.20 0.45 0.20 Wheeze Cough, prol. expir. None
10. 4.2 1.0 0.37 0.12 0.83 0.42 Wheeze Prol. expir. None
11. 3.3 8.0 0.36 0.23 0.01 0.63 Cough Prol. expir. None
12. 6.0 1.0 0.71 0.39 1.02 0.20 Wheeze Cough, prol. expir. None
13. 5.3 1.0 0.21 0.11 1.13 0.67 Cough None
14. 5.1 0.25 0.16 0.22 0.28 0.05 Wheeze Cough, prol. expir., respir. rate None
15. 5.8 1.0 0.45 0.10 0.39 0.21 Prol. expir. None
16. 4.8 0.5 0.62 0.00 0.16 0.01 Cough Prol. expir. None
17. 3.8 8.0 0.42 0.03 0.26 0.01 Cough None
18. 6.3 0.5 0.34 0.16 0.57 0.04 Wheeze Cough None
19. 3.9 0.5 0.32 F 0.31 F Prol. expir. None
20. 5.8 4.0 0.31 0.12 0.50 0.43 Cough Prol. expir. None
Note: Log EMG-Activity-Ratio¼ logarithm of the ratio of the current mean peak-to-bottom value of EMG activity, to that at baseline; PDcs¼ histamine provocation dose at which the
appearance of clinical symptoms was observed; prol. expir.¼prolonged expiration; respir. rate¼ respiration rate. There are 3 missing values because of technical problems.
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Figure 3 shows the mean7standard deviation of
the log EMGAR values of the diaphragm and
intercostal muscles for all children. In both the
mean diaphragmatic and intercostal EMG activity a
linear increase was observed in the 4 histamine
dose steps prior to PDcs. At PDcs, the mean log
EMGAR of the diaphragm and intercostal muscles
was increased with a factor 2.7 (0.4370.18,
P ¼ 0:004) and with a factor 3.2 (0.5170.34,
P ¼ 0:005), respectively, as compared to the mean
baseline values. Ten minutes after administration
of salbutamol the mean log EMGAR of the
diaphragm and intercostal muscles returned to
baseline values.
The mean7standard deviation (SD) of the dia-
phragmatic and intercostal log EMGAR values at the
provocation dose that the clinical symptoms ap-
peared (PDcs), is shown in Table 2.
In 10 out of 20 children the challenge test was
terminated because of wheezing, in eight because
of persistent cough and in two children because a
prolonged expiration was observed. In 15 of 20
positive challenges a combination of wheeze,
persistent cough, a prolonged expiration or an
increased respiration rate was detected. Most
children (85%) coughed at the histamine dose at
which one or more of the four clinical symptoms
were observed (PDcs). The clinical symptoms used
in the present study, for determining the PDcs, do
not necessary reflect the same degree of response.
However, no significant differences in diaphrag-
matic and intercostal log EMGAR values could be
detected at the appearance of the different clinical
symptoms at PDcs.
Discussion
This study shows an increase in the mean surface
diaphragmatic and intercostal log EMG-Activity-
Ratio in association with the appearance of clinical
symptoms during a bronchial challenge test in
asthmatic pre-school children. Ten minutes after
administration of salbutamol the diaphragmatic
and intercostal log EMGAR returned to baseline
values in all challenges.
The applicability of the respiratory EMG techni-
que has been described in patients of all ages for
monitoring disordered respiratory behaviour, in-
cluding diaphragmatic inactivity from phrenic
nerve injury,14,15 augmented expiratory muscle
activity,16 diaphragmatic activity in the presence
of a tension pneumothorax,15 weaning infants from
ventilators,15,17 neural drive and inspiratory neu-
romuscular coupling in patients with asthma.18
Although the transcutaneous EMG technique could
serve as a useful tool in assessing breathing
patterns and airways obstruction (indirectly) in
asthmatic patients, this method is still controver-
sial. It has been argued that with this technique,
difficulties arise in maintaining electrode orienta-
tion with respect to the muscle fibres and in
controlling for influences of variable muscle-to-
electrode distance, because of variations in the
amount of subcutaneous fat.14,15 However, we
minimized the above mentioned influences by using
the ratio of the averaged electrical muscle activity
at a given level of airflow limitation in relation to
that at baseline (EMG Activity Ratio). Using this
ratio, constant factors that influence the amount of
electrical activity measured at both instances will
be reduced to unity and after logarithmic transfor-
mation (log EMGAR) to zero, in fact correcting the
actual value for the baseline value. In the present
study there were three missing values because of
technical problems. However, the assessment of
airway response in an indirect way by measuring
the surface diaphragmatic and intercostal muscle
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Figure 2 Example of an averaged diaphragmatic EMG
recording during a bronchial challenge test, using
histamine (patient 5). Note: On the left: histamine
concentrations (mg/ml); on the right: mean peak-to-
bottom values of the averaged EMG signal; scaling: EMG
(mV) and time (s). Vt¼ tidal breathing before inhalation
of histamine; PBS¼ phosphate buffered saline solution; 1
and 10min*¼ 1min and 10min after administration of
salbutamol, respectively.
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activity during bronchial challenge testing in pre-
school children is innovative. With the develop-
ment of new software, we hope to reduce the
amount of missing values in future studies.
The diaphragmatic and intercostal EMGAR values
increased in association with the appearance of
clinical symptoms during airway response. A larger
variability in intercostals EMG activity was found
compared to diaphragm EMG activity, as can be
seen in Fig. 3. This difference in variability may be
explained in the functional characteristics of the
respiratory muscles. As the diaphragm is the
ARTICLE IN PRESS
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Figure 3 Logarithm of the EMG-Activity-Ratio of the diaphragm and intercostal muscles during histamine-induced
airway response. Note: Mean7SD; PDcs¼ histamine provocation dose at which 1 or more of the clinical symptoms were
observed; Step -1 represents 1 step prior to PDcs; Step –2 represents 2 steps prior to PDcs, and so on; ‘1*’ and ‘10*’¼ 1
and 10min, respectively, after administration of salbutamol. N¼ number of children.
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principal inspiratory muscle, the main function of
the intercostal muscles during tidal breathing is rib
stabilization. When ventilation needs increase, for
example during histamine challenge in asthmatic
patients, the accessory inspiratory muscles are
recruited. However, during the process of airway
response, alternating activity of the diaphragm and
intercostal muscles was observed in some indivi-
duals (Table 1). For example, we found in 2
challenges (patients 2 and 16) a more pronounced
increase in EMGAR of the diaphragm at PDcs, while
in two other challenges (patients 8 and 13) a more
pronounced increase in EMGAR of the intercostal
muscles was observed at PDcs. The activity of the
diaphragm and the intercostal muscles appeared to
alternate at the different histamine dose steps,
suggesting a shift from chest to abdominal breath-
ing. Some children may respond with a more
expressed abdominal breathing pattern while
others prefer chest breathing or the combination
of both. However, in spite of these possible
different breathing strategies, we found a linear
increase in both diaphragmatic and intercostal
mean log EMGAR values in the four histamine dose
steps prior to PDcs. Therefore, monitoring both the
diaphragm and the intercostal muscle activity
could provide additional information in the process
of estimating airway response in pre-school chil-
dren. As the histamine dose-steps increased ex-
ponentially, it may be concluded that the increase
in peak respiratory EMG activity bears a linear
relation with the administered histamine dose in
asthmatic children.
In the present study we used the method as
based on detecting audible clinical symptoms over
the trachea. As most of the methods to assess the
bronchial responsiveness in this specific age group
in clinical practice are not easily applicable or less
reliable, we did not attempt to measure FEV1
values or other flow measures. In an earlier study
we found that lung sounds obtained with a
microphone placed on the trachea corresponded
well with a 20% fall in FEV1 after methacholine
challenge in school children.8 However, in the
latter study wheeze by itself was found to be not
sensitive for bronchial responsiveness. A persistent
cough, an increased respiratory rate, and a
prolonged expiration were more frequently found
during bronchial provocation testing.8 In contrast,
Springer et al.7 and Noviski et al.19 found that only
the occurrence of wheeze correlated well with a
decrease in FEV1. In addition, Noviski et al.
observed the occurrence of cough and increased
respiration rate, but found no association with
either the methacholine concentration causing
wheeze or the concentration causing a fall in FEV1
of 20% (19). Springer et al. found that cough was
not helpful in determining the end point (PDcs).7
Considering these contradictory results it may be
possible that the clinical symptoms used in the
present study, for determining this end point of
provocation, do not necessarily reflect the same
degree of response. In addition, it is possible
that histamine or methacholine may stimulate
irritant receptors in the airways, resulting in
cough rather than inducing bronchoconstriction.
Cough is only an indirect consequence of
bronchoconstriction mediated by irritant receptor
stimulation. As monitoring the activity of the
diaphragm and intercostal muscular system is the
most direct way to obtain information on respira-
tory muscle function, this inter-individual
difference in response to histamine could be
detected by measuring the EMGAR of the dia-
phragm and intercostal muscles. However, when
comparing the respiratory EMGAR values of the
children who responded to histamine with different
clinical symptoms, we could not find a significant
difference in EMGAR of the diaphragm and
intercostal muscles at the moment that these
different clinical symptoms appeared (at PDcs).
Although larger sample sizes would be preferable,
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Table 2 Mean7standard deviation (SD) of the diaphragmatic and intercostal log EMGAR values at the
provocation dose that the clinical symptoms appeared (PDcs).
Clinical symptom N Log EMGAR
Diaphragm Intercostal muscles
Wheeze 10 0.4470.24 0.6270.33
Cough 8 0.4470.14 0.4170.37
Prol. expiration 2 0.3970.09 0.3570.06
Increased respir. rate 0 F F
Note: Diaphragmatic and intercostal log EMGAR was not significantly different at the appearance of the different clinical
symptoms at PDcs.
N¼ number of patients.
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the findings in the present study makes it likely that
wheezing is not the only indicator for the detection
of airway responsiveness in asthmatic pre-school
children. Our observation is supported by Guirau
and colleagues,20 who investigated the correlation
between a methacholine provocation concentra-
tion that induced wheeze (PCwheeze) in healthy and
wheezing children under 2 years of age, and
the clinical evaluation of these children at admis-
sion and at follow-up. They found a significant
inverse gradient between PCwheeze and the severity
of clinical symptoms obtained during clinical
evaluation.
The use of EMG recordings to evaluate diaphrag-
matic activation during tidal breathing and hista-
mine-induced airflow limitation has recently been
criticized because an artefact might occur, created
by changes in lung volume.21,22 It is well estab-
lished that functional residual capacity (FRC) often
increases, accompanied by an increase in tonic
activity of the diaphragm and intercostal muscles
during spontaneous breathing21,22 or during a
histamine-induced airflow limitation.23,24 In the
EMG curves in the present study we noticed that
the tonic activity, defined as electrical activity in
the EMG present at end expiration, slightly in-
creased during histamine induced airway response
(results not shown). Although others have de-
scribed that voluntary diaphragm EMG is system-
atically affected by changes in lung volume,21 Beck
et al. demonstrated that the diaphragm EMG was
not artifactually influenced by lung volume at sub-
maximal contraction levels.25 It should be men-
tioned that, in contrast to our study, an oesopha-
geal electrode was used in these studies to measure
diaphragm activity. Moreover, in a previous study
we observed that histamine-induced changes in
tonic activity of the respiratory muscles did not
modify the association between the FEV1 and the
EMG of the diaphragm and intercostal muscles.11 In
line with the latter study, the change in tonic
activity seemed to have a minor effect on the mean
peak-to-bottom EMG activity and as a result it did
not influence the EMG-Activity-Ratio as a para-
meter for respiratory muscle activity during airway
response.
In conclusion, we found an increase in surface
diaphragmatic and intercostal log EMGAR values in
association with the appearance of clinical symp-
toms during bronchial challenge testing in asth-
matic pre-school children. After administration of
salbutamol the diaphragmatic and intercostal log
EMGAR returned to baseline values in all chal-
lenges. These observations indicate that in pre-
school children histamine induced airway response
and reversibility after inhalation of salbutamol may
be well reflected in the amplitudes of the dia-
phragm and intercostal muscles.
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